XML 46 R34.htm IDEA: XBRL DOCUMENT v3.25.2
GOODWILL AND INTANGIBLE ASSETS (Tables)
 6 Months Ended
Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The Company’s goodwill arose from the GQ Bio Acquisition in February 2025. The change in the carrying value of the Company’s goodwill is summarized as follows (in thousands):
Carrying Value
Balance at December 31, 2023$163,243 
Goodwill impairment(163,243)
Balance at December 31, 2024— 
Goodwill arising from the GQ Bio Acquisition18,099 
Foreign currency adjustments2,201 
Balance at June 30, 2025$20,300 
Schedule of Intangible Assets
Intangible assets, net, consists of the in-process research and development, or IPR&D, from the GQ Bio Acquisition and Flexion Acquisition, developed technology from the Flexion Acquisition and MyoScience Acquisition and customer relationships from the MyoScience Acquisition are summarized as follows (dollar amounts in thousands):
June 30, 2025Gross Carrying ValueForeign Currency AdjustmentsAccumulated AmortizationIntangible Assets, NetWeighted-Average Useful Lives
Developed technologies$590,000 $— $(227,574)$362,426 10 years, 5 months
Customer relationships90 — (56)34 10 years
Total finite-lived intangible assets, net590,090 — (227,630)362,460 
Acquired IPR&D57,366 2,737 — 60,103 
     Total intangible assets, net$647,456 $2,737 $(227,630)$422,563 
December 31, 2024Gross Carrying ValueAccumulated AmortizationIntangible Assets, NetWeighted-Average Useful Lives
Developed technologies$590,000 $(198,934)$391,066 10 years, 5 months
Customer relationships90 (52)38 10 years
     Total finite-lived intangible assets, net590,090 (198,986)391,104 
Acquired IPR&D34,866 — 34,866 
     Total intangible assets, net$624,956 $(198,986)$425,970